Home Gilead Initiates Phase 3 Clinical Program for Tenofovir Alafenamide,...
 

Keywords :   


Gilead Initiates Phase 3 Clinical Program for Tenofovir Alafenamide,...

2013-01-25 02:36:38| Biotech - Topix.net

Gilead Sciences, Inc. today announced the initiation of the first of two Phase 3 clinical trials evaluating a single tablet regimen containing tenofovir alafenamide for the treatment of HIV-1 infection in treatment-nai 1 2ve adults.

Tags: program phase clinical initiates

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
28.09Post-Tropical Cyclone Helene Public Advisory Number 21
28.09Tropical Storm Joyce Public Advisory Number 5
28.09Summary for Tropical Storm Joyce (AT1/AL112024)
28.09Post-Tropical Cyclone Helene Public Advisory Number 21
28.09Tropical Storm Joyce Forecast Discussion Number 5
28.09Tropical Storm Joyce Wind Speed Probabilities Number 5
28.09Tropical Storm Joyce Forecast Advisory Number 5
28.09Hurricane Isaac Graphics
More »